{
    "nctId": "NCT02456129",
    "officialTitle": "An Open-label Study to Evaluate the Effect of Repeated Oral Administration of 200 mg Itraconazole(ITZ) Given Once Daily Over 14 Days on the Single Oral Dose Pharmacokinetics of Vilaprisan (BAY1002670) as Well as Assessment of Absolute Bioavailability Using a Single Intravenous Microtracer Dose of [14C]Vilaprisan in Healthy Postmenopausal Women",
    "inclusionCriteria": "* Body mass index (BMI): 18 \u2264 BMI \u2264 32 kg/m\u00b2\n* Postmenopausal state revealed by:\n\nMedical history, if applicable (natural menopause at least 12 months prior to first study drug administration; or surgical menopause by bilateral ovariectomy at least 3 months prior to first study drug administration), in addition: in women \\< 65 years old, follicle stimulating hormone (FSH) \\> 40 IU/L\n* Must be FEMALE\n* Must have minimum age of 45 Years\n* Must have maximum age of 70 Years",
    "exclusionCriteria": "* Incompletely cured pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination or effects of the study drugs will not be normal\n* Known or suspected liver diseases\n* Clinically relevant findings(e.g. blood pressure, electrocardiogram(ECG); physical and gynecological examination, laboratory examination)"
}